Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 339,588,512
  • Shares Outstanding, K 2,636,352
  • Annual Sales, $ 82,059 M
  • Annual Income, $ 15,119 M
  • 60-Month Beta 0.65
  • Price/Sales 4.21
  • Price/Cash Flow 11.38
  • Price/Book 5.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 2.18
  • Number of Estimates 5
  • High Estimate 2.25
  • Low Estimate 2.10
  • Prior Year 2.10
  • Growth Rate Est. (year over year) +3.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.16 +21.98%
on 03/23/20
143.64 -7.30%
on 03/04/20
-6.87 (-4.91%)
since 03/02/20
3-Month
109.16 +21.98%
on 03/23/20
154.50 -13.82%
on 02/06/20
-12.82 (-8.78%)
since 01/02/20
52-Week
109.16 +21.98%
on 03/23/20
154.50 -13.82%
on 02/06/20
-4.56 (-3.31%)
since 04/02/19

Most Recent Stories

More News
Coronavirus Vaccine Race Intensifies: 3 Stocks in Focus

Given the urgent need for preventing the spread of COVID-19 in future, let's take a look at the companies developing vaccines for the same.

JNJ : 133.15 (+3.37%)
SNY : 43.51 (+1.40%)
MRNA : 33.20 (+11.90%)
NVAX : 13.86 (-1.21%)
TBIO : 9.09 (+9.12%)
Pharma Giant Eli Lilly (LLY) Stock is a Buy During the Coronavirus Economy

Eli Lilly (LLY) stock closed the first quarter above where it started, which was no easy task. So let's dive into why investors might want to buy LLY stock right now...

JNJ : 133.15 (+3.37%)
PFE : 32.87 (+3.53%)
MRK : 76.87 (+4.16%)
LLY : 142.18 (+4.22%)
Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development

The rampant race to introduce a vaccine for the COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.

JNJ : 133.15 (+3.37%)
SNY : 43.51 (+1.40%)
DVAX : 3.46 (+5.49%)
PFE : 32.87 (+3.53%)
MRNA : 33.20 (+11.90%)
GSK : 37.70 (+1.29%)
NVAX : 13.86 (-1.21%)
TBIO : 9.09 (+9.12%)
EBS : 57.03 (+4.97%)
IBB : 107.70 (+3.77%)
XLV : 87.57 (+2.77%)
IMV : 1.5800 (-1.86%)
VHT : 163.97 (+2.74%)
HTBX : 0.5421 (+2.17%)
XBI : 75.93 (+3.64%)
Johnson & Johnson Postpones 2020 Medical Devices Business Review Due to the Coronavirus

Johnson & Johnson (NYSE: JNJ) today announced that, in light of the evolving situation with the coronavirus outbreak (COVID-19), it will reschedule its 2020 Medical Devices Business Review that was planned...

JNJ : 133.15 (+3.37%)
Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

JNJ : 133.15 (+3.37%)
No Foolin': ADP Report Better than Expected

The ADP headline number came out much better than expected at -27K private sector payroll totals; expectations were for -125K.

JNJ : 133.15 (+3.37%)
AMZN : 1,918.83 (+0.58%)
GILD : 76.98 (+6.16%)
Thinking about trading options or stock in Johnson & Johnson, 3M, Procter & Gamble, Teladoc Health, or Walmart?

InvestorsObserver issues critical PriceWatch Alerts for JNJ, MMM, PG, TDOC, and WMT.

MMM : 137.91 (+3.58%)
JNJ : 133.15 (+3.37%)
PG : 114.40 (+4.64%)
TDOC : 159.32 (-1.98%)
WMT : 118.65 (+3.95%)
ADP Report Better than Expected

ADP Report Better than Expected

JNJ : 133.15 (+3.37%)
AMZN : 1,918.83 (+0.58%)
GILD : 76.98 (+6.16%)
Can Retail Pharmacy USA Aid Walgreen Boots' (WBA) Q2 Earnings?

Solid prescription volume growth and brand inflation anticipated to have aided Walgreen Boots' (WBA) Retail Pharmacy USA performance in Q2.

UNH : 240.44 (+1.31%)
JNJ : 133.15 (+3.37%)
MCK : 129.20 (-2.90%)
WBA : 40.32 (-6.30%)
Asian stocks fall on lagging worries about virus, recession

TOKYO (AP) — Asian shares were mixed on Wednesday, on continuing worries about the economic fallout from the pandemic as reports of coronavirus cases keep surging in various regions.

JNJ : 133.15 (+3.37%)
MS : 33.90 (+7.21%)
ABT : 79.44 (+3.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade JNJ with:

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 138.24
1st Resistance Point 135.69
Last Price 133.15
1st Support Level 128.91
2nd Support Level 124.68

See More

52-Week High 154.50
Fibonacci 61.8% 137.18
Last Price 133.15
Fibonacci 50% 131.83
Fibonacci 38.2% 126.48
52-Week Low 109.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar